Our company news

Smooth Drug Development August 2022 News Release

Published on Saturday August 06, 2022

We are working on the following new projects: • We were awarded with a contract for medical writing activities with pelubiprofen

Read more →

Smooth Drug Development July 2022 News Release

Published on Saturday August 06, 2022

We are working on the following new projects: • We were awarded with two contracts for full-service support in bioequivalence trials with Rivaroxaban 10 mg and 20 mg.

Read more →

Smooth Drug Development June 2022 News Release

Published on Wednesday July 06, 2022

We are working on the following new projects: • We signed two contracts for data management services for bioequivalence trials with Paroxetine and Desloratadine.

Read more →

Smooth Drug Development May 2022 News Release

Published on Monday June 06, 2022

We are working on the following new projects: Smooth signed a contract for a bioequivalence trial with Rivaroxaban.

Read more →

CLINICAL TRIALS DAY

Published on Friday May 20, 2022

The International Day of Clinical Research is celebrated on May 20

Read more →

Smooth Drug Development April 2022 News Release

Published on Friday May 06, 2022

We are working on the following new projects: • Smooth is starting a new project in acute nasopharyngitis with our long-term Russian client.

Read more →

Smooth Drug Development March 2022 News Release

Published on Wednesday April 06, 2022

We are working on the following new projects: • We were awarded with Rebamipide trial.

Read more →

Smooth Drug Development February 2022 News Release

Published on Sunday March 06, 2022

We are working on the following new projects: Smooth signed a contract for a trial with Fabomotizole. We were awarded with a medical writing project with INN Budesonide.

Read more →

Smooth Drug Development January 2022 News Release

Published on Sunday February 06, 2022

We are working on the following new projects: • We were awarded with two phase IV full-service trials of Nimesulide. • We signed four new contracts for BE trials with our Russian sponsor

Read more →

Smooth Drug Development November 2021 News Release

Published on Sunday December 12, 2021

We are working on the following new projects: • We signed the contract for the development of a scientific article based on the results of the observation program in chronic hepatitis C genotypes 1 to 6 in the Russian Federation.

Read more →

Smooth Drug Development October 2021 News Release

Published on Friday November 12, 2021

We are working on the following new projects: We signed a new contract for BE trial with our Indian long-term sponsor.

Read more →

Smooth Drug Development CTMS news

Published on Friday November 12, 2021

We are constantly working to improve our IT solutions and now we have set up the eCRF of version 2.0 with advanced data validation capability. New modules

Read more →

Smooth Drug Development September 2021 News Release

Published on Wednesday October 06, 2021

We are working on the following new projects: Our company was awarded with medical writing of an article based on the study report from Chronic Hepatitis C in Russian Federation.

Read more →

Smooth Drug Development August 2021 News Release

Published on Monday September 06, 2021

We are working on the following new projects: We are preparing a contract for a phase 1 clinical trial with Dalteparin sodium. Our company signed a contract signature for the observational program with a top ten pharma.

Read more →

Smooth Drug Development July 2021 News Release

Published on Friday August 06, 2021

We are working on the following new projects: Smooth is signing a contract for a bioequivalence trial of the Ibuprofen with our long-term client in Russia. Our company started activities for regulatory support for a global CRO.

Read more →